AbbVie, Inc. is a company in the U.S. stock market and it is a holding in 213 U.S.-traded ETFs. ABBV has around 101.9M shares in the U.S. ETF market. The largest ETF holder of ABBV is the SPDR S&P 500 ETF Trust (SPY), with approximately 16.07M shares. Investors may also find of interest that the ETF with the largest allocation to ABBV stock is Invesco S&P Ultra Dividend Revenue ETF (RDIV), with a portfolio weight of 5.77%. On average, U.S. ETFs allocate 1.08% of ABBV to their portfolios.
Additionally, ABBV is a favorite stock for Multi-factor and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ABBV as a holding is the Pacer CFRA-Stovall Equal Weight Seasonal Rotation Index ETF (SZNE), with a return of 16.33%.